Search results for "HIV infections"

showing 10 items of 304 documents

Missed opportunities for tuberculosis investigation in a municipal hospital in Ghana: evidence from patient exit interviews

2020

Abstract Background We assessed coverage of symptom screening and sputum testing for tuberculosis (TB) in hospital outpatient clinics in Ghana. Methods In a cross-sectional study, we enrolled adults (≥18 years) exiting the clinics reporting ≥1 TB symptom (cough, fever, night sweats or weight loss). Participants reporting a cough ≥2 weeks or a cough of any duration plus ≥2 other TB symptoms (per national criteria) and those self-reporting HIV-positive status were asked to give sputum for testing with Xpert MTB/RIF. Results We enrolled 581 participants (median age 33 years [IQR: 24–48], 510/581 [87.8%] female). The most common symptoms were fever (348, 59.9%), chest pain (282, 48.5%) and coug…

Adultmedicine.medical_specialtyTuberculosisHIV InfectionsChest painGhanaSensitivity and SpecificitySputum testingWeight lossInternal medicinemedicineHumansTuberculosisOutpatient clinicHospitals Municipalbusiness.industrySputumPublic Health Environmental and Occupational HealthMycobacterium tuberculosisGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalCross-Sectional StudiesInfectious DiseasesSputumFemaleParasitologymedicine.symptombusinessTransactions of The Royal Society of Tropical Medicine and Hygiene
researchProduct

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART

2008

The extent to which HIV-1 proviral DNA mutations cause clinically relevant antiretroviral resistance is still controversial. Paired plasma HIV-1 RNA and whole blood DNA were compared in patients failing HAART to investigate if the additional knowledge of archived mutations could improve the selection of potentially active drugs. Seventy-three HIV-1-infected patients with first/second HAART failure were studied before starting a new regimen based on RNA genotyping. Follow-up data after a 12-week therapy were available. DNA genotyping was retrospectively performed on stored whole blood samples and mutational profiles were compared to those from RNA. The mean number of IAS pol mutations was si…

Anti-HIV AgentsDNA Mutational AnalysisMolecular Sequence DataProviral DNAHIV InfectionsHAART failuremedicine.disease_causeDNA Mutational Analysichemistry.chemical_compoundHIV ProteaseProvirusesAntiretroviral Therapy Highly ActiveVirologyDrug Resistance ViralDNA Mutational AnalysismedicineHumansMulticenter Studies as TopicHIV InfectionTreatment FailureGenotypingRandomized Controlled Trials as TopicCOLD-PCRMutationPlasma RNAbiologyProviruseSequence Analysis RNAAnti-HIV AgentRNASequence Analysis DNAbiology.organism_classificationVirologyHIV Reverse TranscriptaseReverse transcriptaseAntiretroviral genotypic resistanceInfectious DiseaseschemistryDNA ViralMutationLentivirusImmunologyHIV-1RNA ViralDNAantiretroviral genotypic resistance; haart failure; hiv-1; plasma rna; proviral dnaHumanJournal of Medical Virology
researchProduct

Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications

2011

Thirty years after the discovery of HIV infection, there are numerous antiretroviral drugs that control the disease when administered in a potent combination referred to as Highly Active Antiretroviral Therapy (HAART). This therapy reduces the viral load and improves immune system reconstitution, leading to a significant reduction of HIV-related morbidity and mortality. However, HAART does not completely eliminate HIV, so treatment must continue throughout the patient's life. Prolonged use of HAART has been related to long-term adverse events that can compromise patient health. These deleterious effects have been reported for the majority of antiretroviral drugs and are the most common caus…

Anti-HIV AgentsHIV InfectionsDiseasemedicine.disease_causeAntioxidantsImmune systemRisk FactorsAntiretroviral Therapy Highly ActiveDiabetes mellitusDrug DiscoveryAnimalsHumansMedicineAdverse effectPharmacologychemistry.chemical_classificationReactive oxygen speciesbusiness.industrymedicine.diseaseMitochondriaDiscontinuationOxidative StresschemistryImmunologyReactive Oxygen SpeciesbusinessViral loadOxidative stressCurrent Pharmaceutical Design
researchProduct

Serum Malondialdehyde Correlates with Therapeutic Efficiency of High Activity Antiretroviral Therapies (HAART) in HIV-1 Infected Children

2002

Serum malondialdehyde (MDA) levels are increased in human immunodeficiency virus (HIV)-infected children, as it happens also in infected adult individuals. Introduction of high activity antiretroviral therapy (HAART) has promoted an intense decline in morbidity and mortality of these patients. Here we present data on the effect of HAART on serum MDA of HIV+ children and compare them with levels prior to HAART. MDA levels reflect, as other markers do, the HAART-induced clinical improvement and probably also the pro-oxidant/antioxidant side effects of the different drugs used. The results herein allow the proposal of including serum MDA levels as an additional parameter for the clinical manag…

Anti-HIV Agentsbusiness.industryHuman immunodeficiency virus (HIV)virus diseasesHIV InfectionsGeneral Medicinemedicine.disease_causeMalondialdehydeBiochemistryAntiretroviral therapyOxidative Stresschemistry.chemical_compoundchemistryAntiretroviral Therapy Highly ActiveMalondialdehydeImmunologyHIV-1medicineHumansHigh activityDrug Therapy CombinationChildbusinessBiomarkersOxidative stressFree Radical Research
researchProduct

Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic se…

2017

We evaluated the performance of QuantiFERON-TB Gold Plus (QFT-Plus), which includes two Mycobacterium tuberculosis antigen formulations (TB1 and TB2), for detection of latent tuberculosis infection during pregnancy. Eight-hundred-twenty-nine Ethiopian pregnant women (5.9% HIV-positive) were tested with QFT-Plus, with bacteriological sputum analysis performed for women with clinically suspected tuberculosis and HIV-positive women irrespective of clinical presentation. QFT-Plus read-out was categorized according to the conventional cut-off (0.35 IU/ml) for both antigen formulations. In addition, we analysed the distribution of QFT-Plus results within a borderline zone (0.20–0.70 IU/ml), and i…

Bacterial DiseasesRNA virusesPhysiologyMaternal Healthlcsh:MedicineHIV InfectionsPathology and Laboratory MedicineGastroenterologyWhite Blood Cells0302 clinical medicineImmunodeficiency VirusesPregnancyAnimal CellsMedicine and Health SciencesCell Cycle and Cell Division030212 general & internal medicinePregnancy Complications InfectiousYoung adultlcsh:ScienceMultidisciplinarybiologyLatent tuberculosisT CellsObstetrics and GynecologyGestational ageActinobacteriaInfectious DiseasesMedical MicrobiologyCell ProcessesViral PathogensVirusesFemalePathogensCellular Typesmedicine.symptomResearch ArticleAdultmedicine.medical_specialtyTuberculosisImmune CellsImmunologyViral diseasesMicrobiologyMycobacterium tuberculosisInterferon-gammaYoung Adult03 medical and health sciencesAntigenLatent TuberculosisInternal medicineRetrovirusesmedicineHumansTuberculosisMicrobial PathogensSecretionPregnancyBlood CellsBacteriaTuberculin Testbusiness.industryLentiviruslcsh:ROrganismsHIVBiology and Life SciencesMycobacterium tuberculosisCell BiologyTropical Diseasesbiology.organism_classificationmedicine.disease030228 respiratory systemWomen's HealthSputumlcsh:QEthiopiaMitogensPhysiological ProcessesbusinessInterferon-gamma Release TestsPLOS ONE
researchProduct

Scientific HIV research in Africa and the Middle East: a socio-economic demographic analysis

2021

Background: In Africa, HIV/AIDS research is concentrated in certain countries, particularly South Africa. This distribution may not accurately reflect the disease prevalence or the true research efforts of countries.Objectives: To identify HIV/AIDS research productivity of countries in Africa and the Middle East, in absolute terms and adjusted for people living with HIV, population size and economic development.Methods: We identified all the articles and reviews on HIV and AIDS in the Web of Science Core Collection in which African or Middle Eastern countries had participated. After determining the number of documents produced by each country, we adjusted the findings for the number of peop…

Biomedical ResearchPrevalenceDistribution (economics)HIV InfectionsEfficiencyGross domestic productMiddle East03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)Virologyparasitic diseasesPrevalencemedicineHumans030212 general & internal medicineSocioeconomicsDeveloping CountriesProductivity030505 public healthMiddle Eastbusiness.industryPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseDemographic analysisInfectious DiseasesGeographyGross national incomeSocioeconomic FactorsAfrica0305 other medical sciencebusinessAfrican Journal of AIDS Research
researchProduct

Membrane topology of gp41 and amyloid precursor protein: Interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment

2009

AbstractThe amyloid precursor protein (APP), that plays a critical role in the development of senile plaques in Alzheimer disease (AD), and the gp41 envelope protein of the human immunodeficiency virus (HIV), the causative agent of the acquired immunodeficiency syndrome (AIDS), are single-spanning type-1 transmembrane (TM) glycoproteins with the ability to form homo-oligomers. In this review we describe similarities, both in structural terms and sequence determinants of their TM and juxtamembrane regions. The TM domains are essential not only for anchoring the proteins in membranes but also have functional roles. Both TM segments contain GxxxG motifs that drive TM associations within the li…

BiophysicsHIV InfectionsBiologyGp41BiochemistryArticleTransmembrane segmentAmyloid beta-Protein PrecursorMembranes (Biologia)Alzheimer DiseaseAmyloid precursor proteinAnimalsHumansSenile plaqueschemistry.chemical_classificationCell MembraneMembraneHIVCell Biologygp41HIV Envelope Protein gp41Transmembrane proteinVirusCell biologyTransmembrane domainchemistryBiochemistryAmyloid precursor proteinMembrane topologyAlzheimerHIV-1biology.proteinGlycoproteinSequence motifBiochimica et Biophysica Acta (BBA) - Biomembranes
researchProduct

The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation …

2021

HCV infection has been hypothesized as a contributor of poor CD4+ recovery in patients living with HIV (PLWHIV). Aim of this study was to evaluate CD4+, CD8+ cells and CD4/CD8 ratio trends before and after HCV treatment with direct acting agents (DAA) in PLWHIV. HIV/HCV patients enrolled in ICONA and HepaICONA cohorts with HIV-RNA≤50 copies/ml who achieved a sustained viral response after DAA treatment were studied. A linear regression model was used to investigate CD4+, CD8+ and CD4/CD8 changes 12 months before and after DAA treatment. A total of 939 HIV/HCV patients were included, 225 (24.0%) female, median age: 53 years (IQR 50–56). At DAA initiation, CD4+ T cell count was <350 cells/…

CD4-Positive T-LymphocytesHIV InfectionsHepacivirusCD8-Positive T-LymphocytesGastroenterologySettore MED/07chemistry.chemical_compound0302 clinical medicineCd8 t lymphocyteHIV Infection030212 general & internal medicineCoinfectionCD4; CD8; DAA; HCV/HIV; immune activationHcv clearancevirus diseasesMiddle AgedHepatitis CInfectious Diseasesmedicine.anatomical_structureCD4-Positive T-LymphocyteCohort030211 gastroenterology & hepatologyFemaleCD4 CD8 DAA HCV/HIV immune activationHumanImmune activationmedicine.medical_specialtyHCV/HIVT cellAntiviral Agentsimmune activationNO03 medical and health sciencesVirologyInternal medicinemedicineHumansIn patientimmune activation.DAAAntiviral AgentHepaciviruHepatologybusiness.industryRibavirinCD8-Positive T-LymphocyteCD8CD4CD4 Lymphocyte CountchemistryCD4; CD8; DAA; HCV/HIV; immune activation; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Hepacivirus; Humans; Middle Aged; Coinfection; HIV Infections; Hepatitis CbusinessCD8
researchProduct

Serum pancreatic enzymes in human immunodeficiency virus-infected children - A collaborative study of the Italian Society of Pediatric Gastroenterolo…

1998

Numerous studies have shown pancreatic disease in adult human immunodeficiency virus (HIV)-infected patients, but there are very few reports on pediatric patients. Our aim was to determine the prevalence of increased serum pancreatic enzyme levels and their relationship to clinical manifestations of acute pancreatitis in HIV-infected children.Forty-seven consecutive, symptomatic HIV-infected children (24 male; median age, 7.3 years; range, 1-17 years) and 45 sex- and age-matched controls without gastroenterologic disease were enrolled. In all subjects serum total amylase, pancreatic amylase, and lipase were assayed with commercial kits. The following were recorded: disease progression (CDC …

CD4-Positive T-LymphocytesMalemedicine.medical_specialtyPancreatic diseaseAdolescentNutritional StatusHIV InfectionsGastroenterologyImmunopathologyInternal medicineMedicineHumansChildPancreasPediatric gastroenterologyAIDS-Related Opportunistic Infectionsbusiness.industryGastroenterologyInfantLipaseHepatologymedicine.diseasemedicine.anatomical_structurePancreatitisChild PreschoolImmunologyAmylasesVomitingDisease ProgressionAcute pancreatitisFemaleViral diseasemedicine.symptombusinessPancreas
researchProduct

Reversibility of Central Nervous System Adverse Events in Course of Art

2022

The purpose of this study is to evaluate the frequency of central nervous system adverse events (CNS-AE) on dolutegravir (DTG) and non-DTG containing ART, and their reversibility, in the observational prospective SCOLTA cohort. Factors associated with CNS-AE were estimated using a Cox proportional-hazards model. 4939 people living with HIV (PLWH) were enrolled in DTG (n = 1179) and non-DTG (n = 3760) cohorts. Sixty-six SNC-AE leading to ART discontinuation were reported, 39/1179 (3.3%) in DTG and 27/3760 (0.7%) in non-DTG cohort. PLWH naïve to ART, with higher CD4 + T count and with psychiatric disorders were more likely to develop a CNS-AE. The risk was lower in non-DTG than DTG-cohort (aH…

Central Nervous SystemAnti-HIV Agentsadverse eventHIVAnti-HIV AgentHIV InfectionsHIV Infections.dolutegravirCD4 Lymphocyte CountProspective StudieInfectious DiseasespsychiatricreversibilityVirologyneurocognitiveHumansProspective StudiesCNSCNS; adverse events; HIV; dolutegravir; reversibility; neurocognitive; psychiatricHumanViruses; Volume 14; Issue 5; Pages: 1028
researchProduct